BC-1485

BC-1485 is a first-in-class, small molecule inhibitor of FIEL1 (Fibrosis-inducing E3 ligase 1) that exhibits potent activity toward disrupting FIEL1-directed PIAS4 ubiquitination; exhibits >100-fold activity in disrupting the FIEL1-PIAS4 interaction compared with BC-1480; dose-dependently increases PIAS4 protein levels, stabilize PIAS4 in cells; ameliorates fibrosis in murine models.

References 1. Lear T, et al. J Exp Med. 2016 May 30;213(6):1029-46. 2. Lear T, et al. Cytokine. 2016 Dec;88:193-195. View Related Products by Target E3 Ubiquitin Ligase